Akhilesh Kumar Pandey

Akhilesh Kumar Pandey

Auto-generated profile, based on publicly available information

Akhilesh Kumar Pandey

Department of Community Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, 576104

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in Medical Journal Armed Forces India
Verified
Journal Article
Closed access
DSDeepak Sudhakaran
Deepak Sudhakaran
RSRanjitha S. Shetty
Ranjitha S. Shetty
SMSneha D. Mallya
Sneha D. Mallya
ABAshwini Shivakumar Bidnurmath
Ashwini Shivakumar Bidnurmath
APAkhilesh Kumar Pandey
Akhilesh Kumar Pandey
PKPawan Kumar
Pawan Kumar

1 September 2021 in Indian Journal of Critical Care Medicine
Verified
Journal Article
Open access
VSVishal Shanbhag
Vishal Shanbhag
ANArjun Nr
Arjun Nr
APAkhilesh K Pandey
Akhilesh K Pandey
Background: Multiple parameters may be used to prognosticate coronavirus disease 2019 (COVID-19) patients, which are often expensivelaboratory or radiological investigations. We evaluated the utility of age-adjusted Charlson comorbidity index (CCI) as a predictor of outcomein COVID-19 patients treated with remdesivir. Materials and methods: This was a single-center, retrospective study on 126 COVID-19 patients treated with remdesivir. The age-adjusted CCI, length of hospital stay (LOS), need for invasive mechanical ventilation (IMV), and survival were recorded. Results: The mean and standard deviation (SD) of age-adjusted CCI were 3.37 and 2.186, respectively. Eighty-six patients (70.5%) had ageadjusted CCI <= 4, and 36 (29.5%) had age-adjusted CCI >4. Among patients with age-adjusted CCI <= 4, 20 (23.3%) required IMV, whereas in thosewith age-adjusted CCI >4, 19 (52.8%) required IMV (p <0.05, Pearson's chi-square test). In those with age-adjusted CCI <= 4, the mortality was18.6%, whereas it was 41.7% in patients with age-adjusted CCI >4 (p 4. The ROC for age-adjusted CCI for predicting the need for IMV had an AUC of0.696, p = 0.001, and sensitivity 67%, specificity 63%, and 95% CI [0.594, 0.797], for a cutoff score >4. ROC for age-adjusted CCI as a predictorof prolonged LOS (>= 14 days) was insignificant. Conclusion: In COVID-19 patients, the age-adjusted CCI is an independent predictor of the need for IMV (score >4) and mortality (score >4) but is not useful to predict LOS (CTRI/2020/11/029266).

1 August 2021 in Journal of Infection and Public Health
Verified
Journal Article
Open access
DHDruti Hazra
Druti Hazra
KCKiran Chawla
Kiran Chawla
VSVishnu Prasad Shenoy
Vishnu Prasad Shenoy
APAkhilesh K. Pandey
Akhilesh K. Pandey
NSNayana Siddalingaiah
Nayana Siddalingaiah
The recent COVID-19 pandemic became a looming catastrophe over global public health and severely disrupted essential healthcare services like tuberculosis (TB). This study estimated the impact of the COVID-19 in the diagnosis of TB, a microbiology laboratory-based overview. This ambispective observational study was conducted at the Department of Microbiology in a tertiary care hospital in South Karnataka from January 2019 to December 2020. A standardized data collection sheet was prepared to collect the month-wise total number of suspected TB and confirmed TB samples. Data were analyzed using EZR 3.4.3 (R, open-source). Categorical variables were expressed in frequency and percentage. The Chi-square test was performed to test the difference in proportions and p < 0.05 indicated statistical significance. In this study, a significant drop was observed in suspected TB specimens in 2020 compared to 2019, i.e. 54.8% for microscopy, along with 34.2% and 49.7% for Xpert MTB/RIF and MGIT culture respectively. Also, a sharp decline in confirmed TB samples was noted in 2020 with 49%, 43.8%, and 59.7% reduction with microscopy, Xpert MTB/RIF, and MGIT culture respectively, compared to 2019. Another major finding from this study reveals the PTB: EPTB proportion changed from 2.7:1 in 2019 to 2.1:1 in 2020, divulging an overall increase in EPTB sample proportion in 2020 (p = 0.0385). The COVID-19 pandemic adversely impacted the TB diagnostic services, resulting in a significant reduction of active TB case detection. It highlights an urgent need to revise the strategies to control and eliminate TB in this hour of the pandemic crisis.

29 March 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SPSunil Bhaskara Pillai
Sunil Bhaskara Pillai
AKAkshay Kriplani
Akshay Kriplani
ACArun Chawla
Arun Chawla
BSBhaskar K Somani
Bhaskar K Somani
APAkhilesh Pandey
Akhilesh Pandey
PHPADMARAJ HEGDE
PADMARAJ HEGDE
Acute Kidney Injury (AKI) after percutaneous nephrolithotomy (PNL) is a significant complication, but evidence on its incidence is bereft in the literature. The objective of this prospective observational study was to analyze the incidence of post-PNL AKI and the potential risk factors and outcomes. Demographic data collected included age, gender, body mass index (BMI), comorbidities (hypertension, diabetes mellitus), and drug history—particularly angiotensin converting enzyme inhibitors (ACE inhibitors), angiotensin II receptor blockers and beta blockers. Laboratory data included serial serum creatinine measured pre- and postoperation (12, 24, and 48 h), hemoglobin (Hb), total leucocyte count (TLC), Prothrombin time (PT), serum uric acid and urine culture. Stone factors were assessed by noncontrast computerized tomography of kidneys, ureter and bladder (NCCT KUB) and included stone burden, location and Hounsfield values. Intraoperative factors assessed were puncture site, tract size, tract number, operative time, the need for blood transfusion and stone clearance. Postoperative complications were documented using the modified Clavien–Dindo grading system and patients with postoperative AKI were followed up with serial creatinine measurements up to 1 year. Among the 509 patients analyzed, 47 (9.23%) developed postoperative AKI. Older patients, with associated hypertension and diabetes mellitus, those receiving ACE inhibitors and with lower preoperative hemoglobin and higher serum uric acid, had higher incidence of AKI. Higher stone volume and density, staghorn stones, multiple punctures and longer operative time were significantly associated with postoperative AKI. Patients with AKI had an increased length of hospital stay and 17% patients progressed to chronic kidney disease (CKD). Cut-off values for patient age (39.5 years), serum uric acid (4.05 mg/dL) and stone volume (673.06 mm3) were assessed by receiver operating characteristic (ROC) curve analysis. Highlighting the strong predictors of post-PNL AKI allows early identification, proper counseling and postoperative planning and management in an attempt to avoid further insult to the kidney.

28 October 2020 in AIDS Research and Treatment
Verified
Journal Article
Open access
PDF file
SMSneha Mallya
Sneha Mallya
STSravan Reddy T
Sravan Reddy T
AKAsha Kamath
Asha Kamath
APAkhilesh Pandey
Akhilesh Pandey
KSKavitha Saravu
Kavitha Saravu
Longer survival due to use of antiretroviral therapy (ART) has made human immunodeficiency virus- (HIV-) infected individuals prone to chronic diseases such as diabetes, hypertension, and cardiovascular diseases (CVD). Metabolic syndrome (MS), a constellation of risk factors which increase chances of the cardiovascular disease and diabetes, can increase the morbidity and mortality among this population. Hence, the present study was conducted with the objectives of estimating the prevalence and determinants of MS among ART naïve and ART-treated patients and assess their 5-year CVD risk using the reduced version of Data Collection on Adverse Effects of Anti-HIV Drugs (D : A : D) risk prediction model (D : A : D(R)). This hospital-based cross-sectional study included 182 adults aged ≥ 18 years. MS was defined using the National Cholesterol Education Program-Adult Treatment Panel-3 (NCEP ATP-3) criteria. Univariate and multivariate logistic regressions were done to identify the factors associated with MS. Prevalence of MS was 40.1% (95% confidence interval (CI) = 33.0%–47.2%). About 24.7% of the participants had at least a single criterion for MS. Age >45 years (adjusted odds ratio (AOR) = 2.3; 95% CI = 1.1–4.9, p < 0.018 ) and body mass index (BMI) > 23 kg/m2 (AOR = 6.4; 95% CI = 3.1–13.1, p < 0.001 ) were positively associated with MS, whereas daily consumption of high sugar items was inversely associated (AOR = 0.2; 95% CI = 0.1–0.5, p < 0.001 ). More than 50% of the participants were found to have moderate or high 5-year CVD risk. Observed prevalence of MS among HIV patients was higher than other studies done in India. Considering a sizeable number of participants to be having moderate to high CVD risk, culturally appropriate lifestyle interventions need to be planned.

21 July 2023 in Clinical Epidemiology and Global Health
Verified
Journal Article
Open access
VNVarsha Nair
Varsha Nair
SMSneha D. Mallya
Sneha D. Mallya
APAkhilesh Kumar Pandey
Akhilesh Kumar Pandey
PSPrashant Kumar Singh
Prashant Kumar Singh
AYAmit Yadav
Amit Yadav
MKMuralidhar M. Kulkarni
Muralidhar M. Kulkarni